Washington, D.C. 20549

                                   FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): May 7, 2002

                        BioMarin Pharmaceutical Inc.
           (Exact name of registrant as specified in its charter)

         Delaware                      000-26727                 68-0397820
(State or other jurisdiction of       (Commission              (IRS Employer
 incorporation or organization)       File Number)           Identification No.)

371 Bel Marin Keys Boulevard, Suite 210, Novato, California            94949
(Address of principal executive offices)                            (Zip Code)

Registrant's telephone number, including area code:              (415) 884-6700

                                 Not Applicable
           (Former name or former address, if changed since last report)


Item 5.  Other Events.

                  On May 7, 2002, BioMarin Pharmaceutical Inc. announced its
financial results for the quarter ended March 31, 2002. The Registrant's press
release issued on May 7, 2002 is attached hereto as Exhibit 99.1.

Item 7.  Financial Statements, Pro Forma Financial Statements and Exhibits.

         (a)      Financial Statements of Business Acquired.

                  Not Applicable.

         (b)      Pro Forma Financial Information.

                  Not Applicable.

         (c)      Exhibits.

                  Exhibit 99.1      Press Release of the Registrant dated May 7,


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                           BioMarin Pharmaceutical Inc.,
                           a Delaware corporation

Date: May 7, 2002                By: /s/ Fredric D. Price
                                     Fredric D. Price
                                     Chairman and Chief Executive Officer

                           EXHIBIT INDEX

Exhibit No.                Description

Exhibit 99.1               Press Release of the Registrant dated May 7, 2002